EP2884964A4 - Pharmaceutical composition of propofol - Google Patents

Pharmaceutical composition of propofol

Info

Publication number: EP2884964A4
Authority: EP; European Patent Office
Prior art keywords: propofol; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2012-08-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP13833549.2A

Other languages

German (de)

French (fr)

Other versions

EP2884964A2 (en

Inventor

Sougata Pramanick

Mukund Keshav Gurjar

Samit Satish Mehta

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Emcure Pharmaceuticals Ltd

Original Assignee

Emcure Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-08-16

Filing date

2013-08-13

Publication date

2016-01-06

2013-08-13 Application filed by Emcure Pharmaceuticals Ltd filed Critical Emcure Pharmaceuticals Ltd

2015-06-24 Publication of EP2884964A2 publication Critical patent/EP2884964A2/en

2016-01-06 Publication of EP2884964A4 publication Critical patent/EP2884964A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Physiology (AREA)
Dermatology (AREA)
Dispersion Chemistry (AREA)
Anesthesiology (AREA)
Nutrition Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP13833549.2A 2012-08-16 2013-08-13 Pharmaceutical composition of propofol Withdrawn EP2884964A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN2373MU2012		2012-08-16
PCT/IN2013/000495 WO2014033751A2 (en)	2012-08-16	2013-08-13	Pharmaceutical composition of propofol

Publications (2)

Publication Number	Publication Date
EP2884964A2 EP2884964A2 (en)	2015-06-24
EP2884964A4 true EP2884964A4 (en)	2016-01-06

Family

ID=50184537

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP13833549.2A Withdrawn EP2884964A4 (en)	2012-08-16	2013-08-13	Pharmaceutical composition of propofol

Country Status (2)

Country	Link
EP (1)	EP2884964A4 (en)
WO (1)	WO2014033751A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN104490780B (en) *	2015-01-16	2017-04-19	河北一品制药有限公司	Preparation method of propofol fat emulsion injection

Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6028108A (en) *	1998-10-22	2000-02-22	America Home Products Corporation	Propofol composition comprising pentetate
WO2001089474A2 (en) *	2000-05-25	2001-11-29	Astrazeneca Ab	O/w emulsion
US20030207946A1 (en) *	2002-05-02	2003-11-06	Fdl, Inc.	Novel parenteral composition comprising propofol
WO2007052288A2 (en) *	2005-08-05	2007-05-10	Bharat Serums & Vaccines Ltd.	Intravenous propofol emulsion compositions having preservative efficacy
WO2008049178A1 (en) *	2006-10-27	2008-05-02	Cristália Produtos Químicos Farmacêuticos Ltda.	Stable and ready-to-use oil-in-water propofol microemulsion
DE102009003980A1 (en) *	2009-01-07	2010-07-08	B. Braun Melsungen Ag	Formulation, useful for preventing propofol infusion syndrome, comprises propofol and a fatty emulsion with a triglyceride
WO2010082092A1 (en) *	2009-01-13	2010-07-22	Claris Lifesciences Limited	Propofol based anesthetic with preservative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6177477B1 (en) *	1999-03-24	2001-01-23	American Home Products Corporation	Propofol formulation containing TRIS
CN102552136B (en) *	2012-02-09	2013-05-01	清远嘉博制药有限公司	Propofol medium/long-chain injection and preparation method thereof

2013
- 2013-08-13 WO PCT/IN2013/000495 patent/WO2014033751A2/en active Application Filing
- 2013-08-13 EP EP13833549.2A patent/EP2884964A4/en not_active Withdrawn

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6028108A (en) *	1998-10-22	2000-02-22	America Home Products Corporation	Propofol composition comprising pentetate
WO2001089474A2 (en) *	2000-05-25	2001-11-29	Astrazeneca Ab	O/w emulsion
US20030207946A1 (en) *	2002-05-02	2003-11-06	Fdl, Inc.	Novel parenteral composition comprising propofol
WO2007052288A2 (en) *	2005-08-05	2007-05-10	Bharat Serums & Vaccines Ltd.	Intravenous propofol emulsion compositions having preservative efficacy
WO2008049178A1 (en) *	2006-10-27	2008-05-02	Cristália Produtos Químicos Farmacêuticos Ltda.	Stable and ready-to-use oil-in-water propofol microemulsion
DE102009003980A1 (en) *	2009-01-07	2010-07-08	B. Braun Melsungen Ag	Formulation, useful for preventing propofol infusion syndrome, comprises propofol and a fatty emulsion with a triglyceride
WO2010082092A1 (en) *	2009-01-13	2010-07-22	Claris Lifesciences Limited	Propofol based anesthetic with preservative

Also Published As

Publication number	Publication date
WO2014033751A2 (en)	2014-03-06
WO2014033751A3 (en)	2014-05-30
EP2884964A2 (en)	2015-06-24

Publication	Publication Date	Title
HK1209638A1 (en)	2016-04-08	Pharmaceutical compositions
PL3181122T3 (en)	2023-07-31	Dasatinib pharmaceutical composition
ZA201501930B (en)	2016-01-27	Pharmaceutical composition
SI2854768T1 (en)	2017-08-31	Pharmaceutical compositions of pemetrexed
ZA201501928B (en)	2016-01-27	Pharmaceutical antiretroviral composition
EP2832730A4 (en)	2015-09-09	Mirabegron-containing pharmaceutical composition
EP2917314A4 (en)	2016-06-29	Composition of oligomerate
IL237139A0 (en)	2015-04-30	Pharmaceutical compositions of memantine
DK2897594T3 (en)	2020-06-29	PHARMACEUTICAL COMPOSITION
IL266415A (en)	2019-06-30	Novel pharmaceutical composition
PL2887924T3 (en)	2017-09-29	Pharmaceutical compositions of etoricoxib
HK1210710A1 (en)	2016-05-06	Pharmaceutical composition comprising rebamipide
ZA201502987B (en)	2016-11-30	Pharmaceutical composition
EP2851074A4 (en)	2015-06-17	Analgesic pharmaceutical composition
SI2638894T1 (en)	2017-01-31	Pharmaceutical composition containing phospholipid
EP2897590A4 (en)	2016-05-04	Pharmaceutical composition
GB201211153D0 (en)	2012-08-08	Pharmaceutical compositions
EP2884964A4 (en)	2016-01-06	Pharmaceutical composition of propofol
IL238075A0 (en)	2015-05-31	Pharmaceutical compositions
ZA201400751B (en)	2014-12-25	Pharmaceutical composition
GB201221130D0 (en)	2013-01-09	New pharmaceutical composition
GB201207628D0 (en)	2012-06-13	New pharmaceutical composition
GB201207701D0 (en)	2012-06-13	New pharmaceutical composition
GB201219234D0 (en)	2012-12-12	Pharmaceutical compositions
GB201213303D0 (en)	2012-09-05	Pharmaceutical compositions

Legal Events

Date	Code	Title	Description
2015-05-22	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2015-06-24	17P	Request for examination filed	Effective date: 20150316
2015-06-24	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2015-06-24	AX	Request for extension of the european patent	Extension state: BA ME
2015-11-25	DAX	Request for extension of the european patent (deleted)
2016-01-06	A4	Supplementary search report drawn up and despatched	Effective date: 20151209
2016-01-06	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/00 20060101ALI20151203BHEP Ipc: A61K 31/05 20060101ALI20151203BHEP Ipc: A61K 9/107 20060101AFI20151203BHEP Ipc: A61P 23/00 20060101ALI20151203BHEP
2018-11-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2018-12-12	17Q	First examination report despatched	Effective date: 20181108
2020-07-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2020-08-05	18D	Application deemed to be withdrawn	Effective date: 20200303